Compare XNCR & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNCR | NOMD |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2013 | 2015 |
| Metric | XNCR | NOMD |
|---|---|---|
| Price | $33.57 | $11.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $43.83 | $13.74 |
| AVG Volume (30 Days) | ★ 1.5M | 815.2K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 5.96% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | $58.19 | N/A |
| Revenue Next Year | N/A | $1.48 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $10.38 | $8.99 |
| 52 Week High | $40.60 | $13.08 |
| Indicator | XNCR | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 46.23 |
| Support Level | $22.80 | $10.99 |
| Resistance Level | $33.60 | $12.18 |
| Average True Range (ATR) | 2.08 | 0.27 |
| MACD | -0.54 | -0.09 |
| Stochastic Oscillator | 35.21 | 26.04 |
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.